News Website

Endometrial Cryoablation System Market Size, Sales, Average Price and Trends Analysis, till 2032 - openPR.com

Endometrial Cryoablation System Market Size, Sales, Average Price and Trends Analysis, till 2032 openPR.com

Published: May 22, 2025, 11:17 a.m.

Read Full Article

ASCO 2025: A Preview of Advancements in Endometrial Cancer - Medscape

ASCO 2025: A Preview of Advancements in Endometrial Cancer Medscape

Published: May 21, 2025, 5:15 p.m.

Read Full Article

ASCO 2025: A Preview of Advancements in Endometrial and Related Cancers - Medscape

ASCO 2025: A Preview of Advancements in Endometrial and Related Cancers Medscape

Published: May 21, 2025, 5:15 p.m.

Read Full Article

PORTEC-4a Study Supports Personalized Radiotherapy in Early Endometrial Cancer - Medical Dialogues

PORTEC-4a Study Supports Personalized Radiotherapy in Early Endometrial Cancer Medical Dialogues

Published: May 21, 2025, 3 p.m.

Read Full Article

Combinations Targeting PI3K/ AKT/mTOR and MAPK/ERK Pathways Are Under Study in Endometrial Cancer - OncLive

Combinations Targeting PI3K/ AKT/mTOR and MAPK/ERK Pathways Are Under Study in Endometrial Cancer OncLive

Published: May 21, 2025, 2:09 p.m.

Read Full Article

Advanced Endometrial Cancer Pipeline Appears Robust With 25+ - openPR.com

Advanced Endometrial Cancer Pipeline Appears Robust With 25+ openPR.com

Published: May 21, 2025, 12:38 a.m.

Read Full Article

Advanced Endometrial Cancer Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com

Advanced Endometrial Cancer Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Barchart.com

Published: May 20, 2025, 11:32 p.m.

Read Full Article

Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification - Nature

Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification Nature

Published: May 20, 2025, 7:23 p.m.

Read Full Article

Endometrial aging is accompanied by H3K27ac and PGR loss - Nature

Endometrial aging is accompanied by H3K27ac and PGR loss Nature

Published: May 20, 2025, 6:07 p.m.

Read Full Article

Biomarker-Driven Decisions: Insights on Selecting Treatments in Advanced and Recurrent Endometrial Cance - OncLive

Biomarker-Driven Decisions: Insights on Selecting Treatments in Advanced and Recurrent Endometrial Cance OncLive

Published: May 19, 2025, 12:21 p.m.

Read Full Article

Latest Articles

Endometrial Cryoablation System Market Size, Sales, Average Price and Trends Analysis, till 2032 - openPR.com

ASCO 2025: A Preview of Advancements in Endometrial Cancer - Medscape

ASCO 2025: A Preview of Advancements in Endometrial and Related Cancers - Medscape

PORTEC-4a Study Supports Personalized Radiotherapy in Early Endometrial Cancer - Medical Dialogues

Combinations Targeting PI3K/ AKT/mTOR and MAPK/ERK Pathways Are Under Study in Endometrial Cancer - OncLive

Advanced Endometrial Cancer Pipeline Appears Robust With 25+ - openPR.com

Advanced Endometrial Cancer Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com

Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification - Nature

Endometrial aging is accompanied by H3K27ac and PGR loss - Nature

Biomarker-Driven Decisions: Insights on Selecting Treatments in Advanced and Recurrent Endometrial Cance - OncLive

Subscribe to Our Newsletter